Price changes are a fact of life in pharmacy. PHSI monitors many prices that affect all stakeholders in pharmacy.

Pharmaceutical manufacturers monitor the price changes of products in therapeutic categories where they compete. Conclusive and up-to-date monitoring of a drug’s wholesale acquisition cost (WAC) and corresponding average wholesale price (AWP) provides insights into both the reimbursement of prescriptions at the pharmacy and manufacturer strategies. Pricing data can help you analyze and forecast prices for pharmaceutical products in the pipeline and factor into decisions concerning future target drugs.

Pharmacy Benefit Management companies (PBMs) closely monitor generic pricing to establish and maintain appropriate maximum allowable cost (MAC) prices. Published prices play a role in payer reimbursement to the pharmacy and rebates from manufacturers.

Retail pharmacies need current WAC and/or AWP prices to track expected reimbursement results. Plus, monitoring the fluctuating costs in the generic marketplace can ensure pharmacies establish their usual and customary cash price at a competitive and profitable level.

PHSI is an expert in monitoring price changes with valued partners in all 3 stakeholder segments and assists clients navigate the changing competitive landscape.